Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-02-26

FDA Approved: OSPHENA — Original Application (Duchesnay USA, Inc.)

View source ↗

Summary

FDA approved Osphena (ospemifene) from Duchesnay USA, Inc. under its original NDA for the treatment of dyspareunia due to menopause.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Osphena (ospemifene)

Snippet

ORIG AP for OSPHENA (OSPEMIFENE)